PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
17116724-2	2007	Using Mgmt-/- mice, we examined MGMT"s role in protecting from in vivo mutations induced by three different alkylating agents, temozolomide (TMZ), 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) and cyclophosphamide.	Cyclophosphamide	196-212	O-6-methylguanine-DNA methyltransferase	Mus musculus	32-36	
18477655-0	2008	Survival and tumorigenesis in O6-methylguanine DNA methyltransferase-deficient mice following cyclophosphamide exposure.	Cyclophosphamide	94-110	O-6-methylguanine-DNA methyltransferase	Mus musculus	30-68	
17116724-8	2007	Following cyclophosphamide, mutation frequencies significantly increased from 1.8 x 10(-6) in control-treated mice to 12.9 x 10(-6) in Mgmt+/+ and 18.1 x 10(-6) in Mgmt-/- mice, although the difference in Mgmt-/- compared with Mgmt+/+ was not significant.	Cyclophosphamide	10-26	O-6-methylguanine-DNA methyltransferase	Mus musculus	135-139	
17116724-8	2007	Following cyclophosphamide, mutation frequencies significantly increased from 1.8 x 10(-6) in control-treated mice to 12.9 x 10(-6) in Mgmt+/+ and 18.1 x 10(-6) in Mgmt-/- mice, although the difference in Mgmt-/- compared with Mgmt+/+ was not significant.	Cyclophosphamide	10-26	O-6-methylguanine-DNA methyltransferase	Mus musculus	164-168	
17116724-8	2007	Following cyclophosphamide, mutation frequencies significantly increased from 1.8 x 10(-6) in control-treated mice to 12.9 x 10(-6) in Mgmt+/+ and 18.1 x 10(-6) in Mgmt-/- mice, although the difference in Mgmt-/- compared with Mgmt+/+ was not significant.	Cyclophosphamide	10-26	O-6-methylguanine-DNA methyltransferase	Mus musculus	164-168	
17116724-8	2007	Following cyclophosphamide, mutation frequencies significantly increased from 1.8 x 10(-6) in control-treated mice to 12.9 x 10(-6) in Mgmt+/+ and 18.1 x 10(-6) in Mgmt-/- mice, although the difference in Mgmt-/- compared with Mgmt+/+ was not significant.	Cyclophosphamide	10-26	O-6-methylguanine-DNA methyltransferase	Mus musculus	164-168